Lumida
/VERA
⌘K
Vera Therapeutics Inc

Vera Therapeutics Inc

VERA
$35.05USD+4.32%+1.45 today

MARKET CAP

2.5B

P/E (TTM)

FWD P/E

DAY RANGE

$34 – $35

52W RANGE

$23
$56

AI Summary

Stalk
StalkMedium

VERA exhibits a medium-term Stage 2 advancing structure with clear higher highs and higher lows, trading near its rising 9- and 20-day EMAs but below the 50-day and 200-day SMAs. Short-term momentum is neutral as price consolidates around the EMAs without exhaustion, suggesting patience while watching for pullback acceptance into the 9/20 EMA zone. Long-term downtrend remains intact given price below the declining 200-day SMA, posing overhead resistance.

  • FDA accelerated approval of TRUTAKNA enables imminent commercialization.
  • Strong momentum factors underpin recent upward stock trend.
  • Q2 net loss widened to $109.5 M from $76.5 M YoY.
Full analysis →

Buying

5

institutions

Selling

9

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY5.75 M246.64 M+659.66 K+20.5%0.00%
EP

Eversept Partners, LP

Q2 2026

BUY2.21 M94.95 M+39.48 K+8.6%4.93%
WP

Woodline Partners LP

Q2 2026

SELL1.00 M42.95 M+-1.00 M-46.7%0.13%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL374.95 K16.09 M+-44.62 K-4.7%0.02%
RT

Renaissance Technologies LLC

Q2 2026

SELL279.53 K11.99 M+-177.77 K-34.8%0.02%
MM

Millennium Management LLC

Q2 2026

SELL278.66 K11.96 M+-14.84 K+1.3%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL86.00 K3.69 M+-455.96 K-83.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL50.78 K2.30 M+-12.34 K-4.5%0.00%
MG

Man Group Plc

Q2 2026

SELL50.35 K2.16 M+-2.88 K+0.9%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL40.56 K1.74 M+-1.19 M-96.5%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY35.32 K1.42 M+21.38 K+101.4%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY18.32 K786.20 K+2.29 K+21.9%0.04%
AC

Aqr Capital Management LLC

Q2 2026

BUY16.17 K693.98 K+165.00+7.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.50 K64.45 K+-323.00-12.2%0.00%